Clinical study of Arogyavardhini compound and lifestyle modification in management of metabolic syndrome: A double‑blind placebo controlled randomized clinical trial

BACKGROUND: Metabolic syndrome (MS) is a cluster of obesity, hypertriglyceridemia, impaired glucose tolerance, and insulin resistance. The sedentary lifestyle settles on the phenotypical expression of a genetically acquired trait in an obese person. Weight control and a healthy lifestyle remain prim...

Descripción completa

Detalles Bibliográficos
Autores principales: Padhar, Bharatkumar Chhaganbhai, Dave, Alankruta R., Goyal, Mandip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685257/
https://www.ncbi.nlm.nih.gov/pubmed/33281394
http://dx.doi.org/10.4103/ayu.AYU_79_19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685257/
https://www.ncbi.nlm.nih.gov/pubmed/33281394
http://dx.doi.org/10.4103/ayu.AYU_79_19

Ejemplares similares